Literature DB >> 21082224

CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease.

Ho-Chang Kuo1, Chi-Di Liang, Hong-Ren Yu, Chih-Lu Wang, I-Chun Lin, Chieh-An Liu, Jen-Chieh Chang, Chiu-Ping Lee, Wei-Chiao Chang, Kuender D Yang.   

Abstract

OBJECTIVE: Kawasaki disease (KD) is a systemic vasculitis of unknown etiology and primarily affects children less than 5 years of age. Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) has been suggested as a candidate gene for conferring susceptibility to autoimmunity. This study examined the correlation of CTLA-4 gene polymorphisms in KD with and without coronary artery lesions (CAL).
MATERIALS AND METHODS: A total of 233 KD patients and 644 controls were subjected to determination of CTLA-4 polymorphisms at (-318) C/T and (+49) A/G positions by restriction fragment length polymorphism. Susceptibility, CAL, and intravenous immunoglobulin treatment response of KD were then analyzed with genetic variants.
RESULTS: Polymorphisms of CTLA-4 (+49 A/G) and (-318 C/T) were not significantly different between normal children and patients with KD. The CTLA-4 (+49) A allele (AA+AG genotype), however, was significantly associated with CAL formation, especially in female patients.
CONCLUSIONS: This study provides the first evidence supporting the association of CTLA-4 (+49) A/G polymorphism with the CAL formation of KD particularly in female patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21082224     DOI: 10.1007/s10875-010-9484-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  31 in total

1.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.

Authors:  Hironori Ueda; Joanna M M Howson; Laura Esposito; Joanne Heward; Hywel Snook; Giselle Chamberlain; Daniel B Rainbow; Kara M D Hunter; Annabel N Smith; Gianfranco Di Genova; Mathias H Herr; Ingrid Dahlman; Felicity Payne; Deborah Smyth; Christopher Lowe; Rebecca C J Twells; Sarah Howlett; Barry Healy; Sarah Nutland; Helen E Rance; Vin Everett; Luc J Smink; Alex C Lam; Heather J Cordell; Neil M Walker; Cristina Bordin; John Hulme; Costantino Motzo; Francesco Cucca; J Fred Hess; Michael L Metzker; Jane Rogers; Simon Gregory; Amit Allahabadia; Ratnasingam Nithiyananthan; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Polly Bingley; Kathleen M Gillespie; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîrgovişte; David A Savage; A Peter Maxwell; Dennis J Carson; Chris C Patterson; Jayne A Franklyn; David G Clayton; Laurence B Peterson; Linda S Wicker; John A Todd; Stephen C L Gough
Journal:  Nature       Date:  2003-04-30       Impact factor: 49.962

2.  High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease.

Authors:  J Hirao; S Hibi; T Andoh; T Ichimura
Journal:  Int Arch Allergy Immunol       Date:  1997-02       Impact factor: 2.749

Review 3.  Kawasaki disease: infection, immunity and genetics.

Authors:  Chih-Lu Wang; Yu-Tsun Wu; Chieh-An Liu; Ho-Chang Kuo; Kuender D Yang
Journal:  Pediatr Infect Dis J       Date:  2005-11       Impact factor: 2.129

4.  CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.

Authors:  T Kouki; Y Sawai; C A Gardine; M E Fisfalen; M L Alegre; L J DeGroot
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

5.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

6.  Increasing incidence of Kawasaki disease in Japan: nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Izumi Oki; Kazunori Kayaba; Hiroshi Yanagawa
Journal:  Pediatr Int       Date:  2008-06       Impact factor: 1.524

7.  Kawasaki disease in Korea, 2003-2005.

Authors:  Yong-Won Park; Ji-Whan Han; In-Sook Park; Chang-Hwi Kim; Sung-Ho Cha; Jae-Sook Ma; Joon-Sung Lee; Tae-Chan Kwon; Sang-Bum Lee; Chul-Ho Kim; Heung-Jae Lee; Yong-Soo Yun
Journal:  Pediatr Infect Dis J       Date:  2007-09       Impact factor: 2.129

8.  The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.

Authors:  Ho-Chang Kuo; Kuender D Yang; Chi-Di Liang; Chin-Nam Bong; Hong-Ren Yu; Lin Wang; Chih-Lu Wang
Journal:  Pediatr Allergy Immunol       Date:  2007-06       Impact factor: 6.377

9.  CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease.

Authors:  T Matsubara; R Anwar; M Fujiwara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

10.  ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.

Authors:  Yoshihiro Onouchi; Tomohiko Gunji; Jane C Burns; Chisato Shimizu; Jane W Newburger; Mayumi Yashiro; Yoshikazu Nakamura; Hiroshi Yanagawa; Keiko Wakui; Yoshimitsu Fukushima; Fumio Kishi; Kunihiro Hamamoto; Masaru Terai; Yoshitake Sato; Kazunobu Ouchi; Tsutomu Saji; Akiyoshi Nariai; Yoichi Kaburagi; Tetsushi Yoshikawa; Kyoko Suzuki; Takeo Tanaka; Toshiro Nagai; Hideo Cho; Akihiro Fujino; Akihiro Sekine; Reiichiro Nakamichi; Tatsuhiko Tsunoda; Tomisaku Kawasaki; Yusuke Nakamura; Akira Hata
Journal:  Nat Genet       Date:  2007-12-16       Impact factor: 38.330

View more
  13 in total

Review 1.  Genetic polymorphisms in Kawasaki disease.

Authors:  Ho-chang Kuo; Wei-chiao Chang
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

Review 2.  Association of genetic polymorphisms with osteosarcoma risk: a meta-analysis.

Authors:  Zhenyu Bian; Qifang He; Xuepeng Wang; Maoqiang Li; Liulong Zhu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.

Authors:  Ho-Chang Kuo; Kuender D Yang; Suh-Hang Hank Juo; Chi-Di Liang; Wei-Chiao Chen; Yu-Shiuan Wang; Chih-Hung Lee; Edward Hsi; Hong-Ren Yu; Peng-Yeong Woon; I-Chun Lin; Chien-Fu Huang; Daw-Yang Hwang; Chiu-Ping Lee; Li-Yan Lin; Wei-Pin Chang; Wei-Chiao Chang
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

4.  CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population.

Authors:  Ho-Chang Kuo; Mei-Chyn Chao; Yu-Wen Hsu; Ying-Chi Lin; Ying-Hsien Huang; Hong-Ren Yu; Ming-Feng Hou; Chi-Di Liang; Kuender D Yang; Wei-Chiao Chang; Chih-Lu Wang
Journal:  ScientificWorldJournal       Date:  2012-05-02

5.  Polymorphic sites at the immunoregulatory CTLA-4 gene are associated with chronic chagas disease and its clinical manifestations.

Authors:  Fabrício C Dias; Tiago da S Medina; Celso T Mendes-Junior; Roberto O Dantas; Cristina W Pissetti; Virmondes Rodrigues Junior; Renata Dellalibera-Joviliano; José A Marin-Neto; Fredy R S Gutierrez; Philippe Moreau; João S Silva; Eduardo A Donadi
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

Review 6.  Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.

Authors:  Yu-wen Lv; Jing Wang; Ling Sun; Jian-min Zhang; Lei Cao; Yue-yue Ding; Ye Chen; Ji-juan Dou; Jie Huang; Yi-fei Tang; Wen-tao Wu; Wei-rong Cui; Hai-tao Lv
Journal:  Comput Math Methods Med       Date:  2013-03-06       Impact factor: 2.238

7.  Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.

Authors:  Chih-Jen Chen; Fu-Chen Huang; Mao-Meng Tiao; Ying-Hsien Huang; Li-Yan Lin; Hong-Ren Yu; Kuender D Yang; Yi-Chuan Huang; Chih-Cheng Chen; Wei-Chiao Chang; Ho-Chang Kuo
Journal:  ScientificWorldJournal       Date:  2012-06-18

8.  Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan.

Authors:  Peng Yeong Woon; Wei Chiao Chang; Chi-Cheng Liang; Chun Hung Hsu; Sukhontip Klahan; Ying-Hsien Huang; Wei-Pin Chang; Ho-Chang Kuo
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-27       Impact factor: 2.629

9.  A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease.

Authors:  Ho-Chang Kuo; Yu-Wen Hsu; Chung-Min Wu; Shawn Hsiang-Yin Chen; Kuo-Sheng Hung; Wei-Pin Chang; Kuender D Yang; Kai-Sheng Hsieh; Wei-Chiao Chen; Yoshihiro Onouchi; Wei-Chiao Chang
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

10.  Common carotid artery intima-media thickness is useful for diagnosis of the acute stage of Kawasaki disease.

Authors:  Ting-Hsin Wu; Hsuan-Chang Kuo; You-Lin Tain; Kuan-Miao Lin; Ho-Chang Kuo; Shao-Ju Chien
Journal:  BMC Pediatr       Date:  2014-04-10       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.